COVID-19 pneumonia and pregnancy; a systematic review and meta-analysis.


Journal

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
ISSN: 1476-4954
Titre abrégé: J Matern Fetal Neonatal Med
Pays: England
ID NLM: 101136916

Informations de publication

Date de publication:
May 2022
Historique:
pubmed: 21 5 2020
medline: 1 4 2022
entrez: 21 5 2020
Statut: ppublish

Résumé

The new SARS-CoV-2 originated from Wuhan, China is spreading rapidly worldwide. A number of SARS-CoV-2 positive pregnant women have been reported. However, more information is still needed on the pregnancy outcome and the neonates regarding COVID-19 pneumonia. A systematic search was done and nine articles on COVID-19 pneumonia and SARS-CoV-2 positive pregnant women were extracted. Some maternal-fetal characteristics were extracted to be included in the meta-analysis The present meta-analysis was conducted on 87 SARS-CoV-2 positive pregnant women. Almost 65% of the patients reported a history of exposure to an infected person, 78% suffered from mild or moderate COVID-19, 99.9% had successful termination, 86% had cough, and 68% had fever ( Currently, no evidence of vertical transmission has been suggested at least in late pregnancy. No hazards have been detected for fetuses or neonates. Although pregnant women are at an immunosuppressive state due to the physiological changes during pregnancy, most patients suffered from mild or moderate COVID-19 pneumonia with no pregnancy loss, proposing a similar pattern of the clinical characteristics of COVID-19 pneumonia to that of other adult populations.

Sections du résumé

BACKGROUND UNASSIGNED
The new SARS-CoV-2 originated from Wuhan, China is spreading rapidly worldwide. A number of SARS-CoV-2 positive pregnant women have been reported. However, more information is still needed on the pregnancy outcome and the neonates regarding COVID-19 pneumonia.
MATERIAL AND METHODS UNASSIGNED
A systematic search was done and nine articles on COVID-19 pneumonia and SARS-CoV-2 positive pregnant women were extracted. Some maternal-fetal characteristics were extracted to be included in the meta-analysis
RESULTS UNASSIGNED
The present meta-analysis was conducted on 87 SARS-CoV-2 positive pregnant women. Almost 65% of the patients reported a history of exposure to an infected person, 78% suffered from mild or moderate COVID-19, 99.9% had successful termination, 86% had cough, and 68% had fever (
CONCLUSION UNASSIGNED
Currently, no evidence of vertical transmission has been suggested at least in late pregnancy. No hazards have been detected for fetuses or neonates. Although pregnant women are at an immunosuppressive state due to the physiological changes during pregnancy, most patients suffered from mild or moderate COVID-19 pneumonia with no pregnancy loss, proposing a similar pattern of the clinical characteristics of COVID-19 pneumonia to that of other adult populations.

Identifiants

pubmed: 32429786
doi: 10.1080/14767058.2020.1763952
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1652-1659

Commentaires et corrections

Type : CommentIn

Auteurs

Maryam Kasraeian (M)

Maternal-fetal medicine Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Marjan Zare (M)

Maternal-fetal medicine Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Homeira Vafaei (H)

Maternal-fetal medicine Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Nasrin Asadi (N)

Maternal-fetal medicine Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Azam Faraji (A)

Maternal-fetal medicine Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Khadijeh Bazrafshan (K)

Maternal-fetal medicine Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Shohreh Roozmeh (S)

Maternal-fetal medicine Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH